Continuous Glucose Monitoring System

  • Sensors identified as scrap were diverted and sold by third-party
  • Company: Dexcom, Inc.
  • Medical Devices
  • FDA
  • May 26, 2026

Product details

  • Continuous Glucose Monitoring System

Company announcement

Dexcom, Inc. announced that certain lots of Dexcom G7 sensors, originally designated as scrap, were stolen and sold by third parties.

Two affected lots have been identified: 1725204004 and 1725069002.

The issue primarily impacts the United States.

There have been no reported severe adverse events associated with the stolen product.

Risk:

Lot 1725204004: Dexcom G7 sensors that are not properly sterilized have an increased risk of skin infection. Lot 1725069002: Dexcom G7 sensors from a lot with an elevated internal testing failure rate have an increased risk of having no sensor readings available.

Impacted states: Nationwide

Products:

- Dexcom G7 sensors

Contact

For more information, call 1-844-478-1600.

View the original FDA notice

Browse all recalls

Related recalls